Philipp J Rauch
Overview
Explore the profile of Philipp J Rauch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
1344
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rauch P, Gopakumar J, Silver A, Nachun D, Ahmad H, McConkey M, et al.
Nat Cardiovasc Res
. 2024 Aug;
2(9):805-818.
PMID: 39196062
Clonal hematopoiesis of indeterminate potential (CHIP) is defined by the presence of a cancer-associated somatic mutation in white blood cells in the absence of overt hematological malignancy. It arises most...
2.
3.
4.
Ellegast J, Alexe G, Hamze A, Lin S, Uckelmann H, Rauch P, et al.
Cancer Discov
. 2022 Apr;
12(7):1760-1781.
PMID: 35405016
Significance: This study exploits inflammatory programs inherent to AML blasts to identify genetic vulnerabilities in this disease. In doing so, we determined that AML cells are dependent on the transcriptional...
5.
Ellegast J, Rauch P, Kovtonyuk L, Muller R, Wagner U, Saito Y, et al.
Blood
. 2016 Sep;
128(17):2130-2134.
PMID: 27581357
Favorable-risk human acute myeloid leukemia (AML) engrafts poorly in currently used immunodeficient mice, possibly because of insufficient environmental support of these leukemic entities. To address this limitation, we here transplanted...
6.
Rauch P, Ellegast J, Widmer C, Fritsch K, Goede J, Valk P, et al.
Blood
. 2016 Aug;
128(18):2253-2257.
PMID: 27574191
Although the molecular pathways that cause acute myeloid leukemia (AML) are increasingly well understood, the pathogenesis of peripheral blood cytopenia, a major cause of AML mortality, remains obscure. A prevailing...
7.
Nath S, Sheridan A, Rauch P, Yu J, Minja F, Vortmeyer A, et al.
J Neurooncol
. 2014 Feb;
117(2):303-10.
PMID: 24504499
Brain metastases treated with stereotactic radiosurgery may show delayed enlargement on post-treatment imaging that is of ambiguous etiology. Histopathologic interpretation of brain specimens is often challenging due to the presence...
8.
Alomari A, Rauch P, Orsaria M, Minja F, Chiang V, Vortmeyer A
J Neurooncol
. 2014 Jan;
117(1):33-42.
PMID: 24442402
Progressively enlarging encephalopathic changes are now well-documented effects of gamma knife radiosurgery (GKRS) occurring ~3-30 months after treatment of both benign and malignant brain lesions. These changes can be variably...
9.
Cortez-Retamozo V, Etzrodt M, Newton A, Ryan R, Pucci F, Sio S, et al.
Immunity
. 2013 Jan;
38(2):296-308.
PMID: 23333075
Macrophages frequently infiltrate tumors and can enhance cancer growth, yet the origins of the macrophage response are not well understood. Here we address molecular mechanisms of macrophage production in a...
10.
Cortez-Retamozo V, Etzrodt M, Newton A, Rauch P, Chudnovskiy A, Berger C, et al.
Proc Natl Acad Sci U S A
. 2012 Feb;
109(7):2491-6.
PMID: 22308361
Tumor-associated macrophages (TAMs) and tumor-associated neutrophils (TANs) can control cancer growth and exist in almost all solid neoplasms. The cells are known to descend from immature monocytic and granulocytic cells,...